Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01360671

IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn

Persistent Pulmonary Hypertension of the Newborn Clinical Trial

Official title:
An Open Label Single Arm, Single Centre Study to Investigate the Safety and Efficacy of IV Sildenafil in Neonates With Persistent Pulmonary Hypertension of the Newborn (PPHN)

Clinical Trial Summary

To determine the efficacy of iv sildenafil in term and near term infants with PPHN (persistent pulmonary hypertension of the newborn), by measuring the need for inhaled nitric oxide (iNO) or extracorporeal membrane oxygenation (ECMO) compared to a historical control group not treated with sildenafil.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01360671
Study type Interventional
Source Pfizer
Contact
Status Withdrawn
Phase Phase 2
Start date March 2012
Completion date April 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT04328636 - Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn Phase 1/Phase 2
Recruiting NCT02380040 - Plethismographic Perfusion Index in Neonates N/A
Terminated NCT02261883 - Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn Phase 2
Completed NCT04841070 - NEURodevelopmental Outcome After Persistent Pulmonary Hypertension Of the Newborn N/A
Recruiting NCT05741229 - The Effect Of Nebulizied Nitroglycerin As An Adjuvant Therapy For Persistent Pulmonary Hypertension Of Newborns N/A
Recruiting NCT00710177 - PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
Completed NCT01670136 - Pharmacokinetics of Sildenafil in Premature Infants Phase 1
Completed NCT02940327 - Markers of Inflammation and Lung Recovery in ECMO Patients for PPHN
Terminated NCT01389856 - Persistent Pulmonary Hypertension of the Newborn Phase 3
Terminated NCT01069861 - Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN) Phase 2
Active, not recruiting NCT02951130 - Milrinone in Congenital Diaphragmatic Hernia Phase 2
Enrolling by invitation NCT04938167 - Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hypertension N/A
Not yet recruiting NCT04379180 - Population Pharmacokinetics and Dosage Individualization of Oral Pulmonary Vasodilators in PPHN